Therapeutic Maintenance Effect of Finasteride 1 Mg Every Other Month Regimen in Androgenetic Alopecia: A Prospective Cohort Study

    January 2024 in “ The Journal of Dermatology ”
    Ki‐Hun Kim, Soon Hyo Kwon, Woo‐Young Sim, Bark Lynn Lew
    Image of study
    TLDR Taking finasteride every other month can still help with hair loss but may be less effective over time compared to taking it daily.
    The study involved 100 male patients with androgenetic alopecia (AGA), of which 36 completed the study. They were treated with finasteride, either daily or every other month (EOM), for 2 years. Both regimens maintained the therapeutic effect of finasteride, as assessed by global photographic assessment, hair density, and serum and urine concentrations of androgen hormones. However, the EOM group showed a decrease in hair density in the second year, while the daily group showed an increase. The difference in hair density between the two groups was not statistically significant. The study concluded that the EOM regimen could be a viable option for patients with AGA, potentially reducing the financial, physical, and psychological burdens associated with daily intake. Differences in DHT and DHT/T between the good and bad response groups were not statistically significant, but further investigation may reveal a correlation between therapeutic effect and androgenetic hormone.
    Discuss this study in the Community →

    Research cited in this study

    9 / 9 results

    Related Community Posts Join

    6 / 1000+ results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 4 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  134 upvotes 8 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

      community Why does finasteride stop working?

      in Finasteride/Dutasteride  26 upvotes 2 months ago
      Finasteride may seem less effective over time due to increased DHT sensitivity or aging, but it still suppresses DHT. Switching to dutasteride offers stronger DHT suppression but may increase estrogen levels.

    Related Research

    8 / 8 results